secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0001493152-23-039745
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals (MGRX) gets Nasdaq notice for equity of $1.35M vs $2.5M minimum
------------------------------------------------------------------------------

- Stockholders' equity of $1,354,821 as of Sep 30, 2023, below Nasdaq's $2.5M continued listing requirement.
- Must submit a compliance plan by Dec 18, 2023; Nasdaq may grant up to 180-day extension if plan accepted.
- Company also not in compliance with minimum bid price of $1.00 per share, previously reported.
- Failure to regain compliance could result in delisting; management is evaluating options to address the deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315223039745/0001493152-23-039745-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315223039745/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-039745

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer